These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8881943)
21. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202 [TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance. Yu DS; Ma CP; Chang SY Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629 [TBL] [Abstract][Full Text] [Related]
23. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041 [TBL] [Abstract][Full Text] [Related]
24. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms]. Gai XD; Li GL; Huang JZ; Xue HJ; Wang D Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674 [TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas]. Qin F; Qin X; Zhang X; Jia HW Ai Zheng; 2002 Feb; 21(2):167-70. PubMed ID: 12479068 [TBL] [Abstract][Full Text] [Related]
26. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas. Kubo H; Sumizawa T; Koga K; Nishiyama K; Takebayashi Y; Chuman Y; Furukawa T; Akiyama S; Ohi Y Int J Cancer; 1996 Dec; 69(6):488-94. PubMed ID: 8980253 [TBL] [Abstract][Full Text] [Related]
27. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR]. Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032 [TBL] [Abstract][Full Text] [Related]
28. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance]. Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485 [TBL] [Abstract][Full Text] [Related]
29. The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. Tomonaga M; Oka M; Narasaki F; Fukuda M; Nakano R; Takatani H; Ikeda K; Terashi K; Matsuo I; Soda H; Cowan KH; Kohno S Jpn J Cancer Res; 1996 Dec; 87(12):1263-70. PubMed ID: 9045962 [TBL] [Abstract][Full Text] [Related]
30. [Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer]. Zhang L; Yang H; Dong D Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):60-4. PubMed ID: 21144284 [TBL] [Abstract][Full Text] [Related]
31. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314 [TBL] [Abstract][Full Text] [Related]
32. Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma. Yang W; Zeng X; Chen C; Chen Z; Du G J Tongji Med Univ; 2000; 20(4):311-4. PubMed ID: 12840920 [TBL] [Abstract][Full Text] [Related]
33. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse. Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583 [TBL] [Abstract][Full Text] [Related]
34. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa. Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048 [TBL] [Abstract][Full Text] [Related]
35. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome. Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273 [TBL] [Abstract][Full Text] [Related]
36. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance. Xiang F; Yu W; Shen Y; Wu C; Wang Y Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):398-405. PubMed ID: 21126409 [TBL] [Abstract][Full Text] [Related]
37. Significance of MDR-related proteins in the postoperative individualized chemotherapy of gastric cancer. Yu P; Cheng X; Du Y; Yang L; Huang L J Cancer Res Ther; 2015; 11(1):46-50. PubMed ID: 25879335 [TBL] [Abstract][Full Text] [Related]
38. Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse. Ramachandran C; Mead D; Wellham LL; Sauerteig A; Krishan A Biochem Pharmacol; 1995 Feb; 49(4):545-52. PubMed ID: 7872960 [TBL] [Abstract][Full Text] [Related]
39. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias. Beck J; Niethammer D; Gekeler V Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350 [TBL] [Abstract][Full Text] [Related]
40. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]